Previous studies investigating associations between genetic variants and late-onset Alzheimer's disease (LOAD)-related cognitive functions included primarily European-ancestry individuals and utilized linear models on neuropsychological test scores with ceiling effects.
Objective
Investigate associations between LOAD-related single nucleotide polymorphisms (SNPs) and neuropsychological test scores by applying the superior approach, Tobit (versus linear) regression models, to identify population-specific SNPs associated with cognitive performance across multiple genetic ancestry groups.
Methods
National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDS) and Alzheimer's Disease Genetics Consortium (ADGC) provided phenotype and genotype data on Alzheimer's Disease Research Center (ADRC) participants, respectively. Using the ADGC genotype data, genetic ancestry groups were identified for ADRC participants, including non-Hispanic White (NHW), African American (AA), Hispanic, and Asian. Tobit and linear models were applied to examine genetic associations of 84 LOAD-related SNPs with cognitive performance at the most recent visit, utilizing the NACC UDS data.
Results
Genetic architectures varied across genetic ancestry groups. The Tobit model detected the association of TMEM106B-rs13237518(A) missed by the linear model. APOE-rs429358(C) was negatively associated with global cognitive function across ancestry groups. Subgroup analyses recognized associations among participants with a cognitive status of dementia: ADAMTS1-rs2830489(T) for Asians and SHARPIN-rs34173062(A) for Hispanics.
Conclusions
Tobit models demonstrated superior model fit for genetic association analyses of global cognition and language test scores exhibiting ceiling effects.
GatzMReynoldsCAFratiglioniL, et al.Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry2006; 63: 168–174.
3.
BellenguezCKüçükaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet2022; 54: 412–436.
4.
WightmanDPJansenIESavageJE, et al.A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet2021; 53: 1276–1282.
5.
KunkleBWGrenier-BoleyBSimsR, et al.Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates aβ, tau, immunity and lipid processing. Nat Genet2019; 51: 414–430.
6.
ShigemizuDAsanomiYAkiyamaS, et al.Whole-genome sequencing reveals novel ethnicity-specific rare variants associated with Alzheimer’s disease. Mol Psychiatr2022; 27: 2554–2562.
7.
XionCLuoJCobleD, et al.Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia. Alzheimers Dement2020; 16: 589–597.
8.
ReitzCJunGNajA, et al.Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ɛ4, and the risk of late-onset Alzheimer disease in African Americans. JAMA2013; 309: 1483–1492.
9.
Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures: special report: race, ethnicity and Alzheimer’s in America. Alzheimers Dement2021; 17: 376–406.
10.
WangBChibnikLBChoiSH, et al.Association of genetic risk of Alzheimer's disease and cognitive function in two European populations. Sci Rep2025; 15: 6410.
11.
WendelBPapiolSAndlauerTFM, et al.A genome-wide association study of the longitudinal course of executive functions. Transl Psychiatry2021; 11: 386.
12.
RietveldCAEskoTDaviesG, et al.Common genetic variants associated with cognitive performance identified using the proxy-phenotype method. Proc Natl Acad Sci U S A2014; 111: 13790–13794.
13.
ShervaRGrossAMukherjeeS, et al.Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways. Alzheimers Dement2020; 16: 1134–1145.
14.
DaviesGLamMHarrisSE, et al.Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun2018; 9: 2098.
15.
FolseinMFFolsteinSEMcHughPR. Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
16.
WuXFardoDWKatsumataY. Comparison among different modeling methods on the mini-mental state examination. Alzheimers Dement2023; 19: e083150.
17.
Franco-MarinaFGarcía-GonzálezJJWagner-EcheagarayF, et al.The mini-mental state examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population. Int Psychogeriatr2010; 22: 72–81.
18.
BortnikKEBooneKBWenJ, et al.Survey results regarding use of the Boston naming test: Houston, we have a problem. J Clin Exp Neuropsychol2013; 35: 857–866.
19.
AgogoGOMwambiHShiX, et al.Modeling of correlated cognitive function and functional disability outcomes with bounded and missing data in a longitudinal aging study. Behav Res Methods2022; 54: 2949–2961.
20.
Jacqmin-GaddaHFabrigouleCCommengesD, et al.A 5-year longitudinal study of the Mini-mental state examination in normal aging. Am J Epidemiol1997; 145: 498–506.
21.
TobinJ. Estimation of relationships for limited dependent variables. Econometrica1958; 26: 24–36.
22.
GrahamPLRyanLMLuszczMA. Joint modelling of survival and cognitive decline in the Australian longitudinal study of ageing. J R Stat Soc Ser C Appl Stat2010; 60: 221–238.
23.
TwiskJRijmenF. Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects. J Clin Epidemiol2009; 62: 953–958.
24.
WangLZhangZMcArdleJJ, et al.Investigating ceiling effects in longitudinal data analysis. Multivariate Behav Res2009; 43: 476–496.
25.
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature2015; 526: 68–74.
26.
Diaz-PapkovichAAnderson-TrocméLBen-EghanC, et al.UMAP Reveals cryptic population structure and phenotype heterogeneity in large genomic cohorts. PLoS Genet2019; 15: e1008432.
27.
McInnesLHealyJSaulN, et al.UMAP: uniform manifold approximation and projection. J Open Source Softw2018; 3: 861.
28.
National Academies of Sciences, Engineering, and Medicine. 2023. Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field. Washington, DC: The National Academies Press, 2023.
29.
WeintraubSSalmonDMercaldoN, et al.The Alzheimer's disease Centers’ uniform data set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord2009; 23: 91–101.
30.
NaseddineZSPhillipsNABedirianV, et al.The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc2005; 53: 695–699.
31.
KaplanEFGoodglassHWeintraubS. The Boston Naming Test. 2nd Edition. Philadelphia: Lea & Febiger, 1983.
32.
StasenkoAJacobsDMSalmonDP, et al.The multilingual naming test (MINT) as a measure of picture naming ability in Alzheimer's disease. J Int Neuropsychol Soc2019; 25: 821–833.
33.
MonsellSEDodgeHHZhouXH, et al.Results from the NACC uniform data set neuropsychological battery crosswalk study. Alzheimer Dis Assoc Disord2016; 30: 134–139.
34.
DasSForerLSchonherrS, et al.Next-generation genotype imputation service and methods. Nat Genet2016; 48: 1284–1287.
35.
PurcellSNealeBTodd-BrownK, et al.PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet2007; 81: 559–575.
36.
ChangCCChowCCTellierLC, et al.Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience2015; 4: 7.
37.
KleiberCZeileisA. AER: Applied Econometrics with R. R package version 1.2-7, 2019.
38.
PinheiroJCBatesDMDebRoyS, et al.nlme: linear and nonlinear mixed effects models. R package version 3.1-164, 2023.
39.
MorrisJCWeintraubSChuiHC, et al.The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord2006; 20: 210–216.
40.
ChakrabartiAGhoshJK. AIC, BIC and recent advances in model selection. In: BandyopadhyayPSForsterMR (eds) Philosophy of statistics. Oxford: North-Holland, 2011, pp.583–605.
41.
KatsumataYShadeLMHohmanTJ, et al.Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis2022; 174: 105880.
42.
AndrewsSJMcFallGPBoothA, et al.Association of Alzheimer's disease genetic risk loci with cognitive performance and decline: a systematic review. J Alzheimers Dis2019; 69: 1109–1136.
43.
GaliotoRGarciaSSpitznagelMB, et al.The Mini-mental state exam (MMSE) is not sensitive to cognitive impairment in bariatric surgery candidates. Surg Obes Relat Dis2014; 10: 553–557.
44.
KangMAngTFADevineSA, et al.A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores. Mol Neurodegener2023; 18: 40.
45.
SahaOMelo de FariasARPelletierA, et al.The Alzheimer's disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons. Mol Psychiatry2024; 29: 2634–2646.
46.
PalomerEBuechlerJSalinasPC. Wnt signaling deregulation in the aging and Alzheimer's brain. Front Cell Neurosci2019; 13: 227.
47.
KostesWWBrafmanDA. The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression. Cells2023; 12: 1204.
48.
NelsonPTDicksonDWTrojanowskiJQ, et al.Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain2019; 142: 1503–1527.
49.
FengTLuanLKatzII, et al.TMEM106B Deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss. Acta Neuropathol Commun2022; 10: 33.
50.
DemingYFilipelloFCignarellaF, et al.The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Sci Transl Med2019; 11: eaau2291.
51.
WinfreeRLNolanEDumitrescuL, et al.Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology. Mol Neurodegener2024; 19: 41.
52.
SooCCBrandenburgJTNebelA, et al.Genome-wide association study of population-standardised cognitive performance phenotypes in a rural South African community. Commun Biol2023; 6: 328.
53.
JianXSoferTTarrafW, et al.Genome-wide association study of cognitive function in diverse Hispanics/Latinos: results from the Hispanic community health study/study of latinos. Transl Psychiatry2020; 10: 245.
54.
MiyashitaAKikuchiMHaraN, et al.Genetics of Alzheimer’s disease: an east Asian perspective. J Hum Genet2023; 68: 115–124.
55.
MinersSvan HelmondZBarkerR, et al.Genetic variation in MME in relation to neprilysin protein and enzyme activity, aβ levels, and Alzheimer's disease risk. Int J Mol Epidemiol Genet2012; 3: 30–38.
56.
AsanomiYShigemizuDAkiyamaS, et al.A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease. J Hum Genet2022; 67: 203–208.
57.
KrishnanDMenonRNMathuranathPS, et al.A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease. Neurobiol Aging2020; 93: 131–141.
58.
LemarchantSPruvostMMontanerJ, et al.ADAMTS Proteoglycanases in the physiological and pathological central nervous system. J Neuroinflammation2013; 10: 899.
59.
YangHKhalilRA. ADAM And ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease. Adv Pharmacol2022; 94: 255–363.
60.
ZhongSKhalilRA. A disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease. Biochem Pharmacol2019; 164: 188–204.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
